Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Disrupting Scientific Friction: How Ome Ogbru Uses AI to Free Real Science


      News provided by

      Disruption Interruption

      May 07, 2026, 15:10 ET

      Share this article

      Share this article


      Life sciences runs on breakthrough innovation, yet much of the industry still operates through broken workflows and manual processes that drain time from experts. Ome Ogbru, PharmD, CEO and founder of AINGENS, says the problem is no longer a lack of intelligence, but how the work gets done.

      TAMPA BAY, Fla., May 7, 2026 /PRNewswire/ -- Pharma does not have a science problem. It has a workflow problem. On this episode of Disruption Interruption, host Karla Jo Helms (KJ) speaks with Ome Ogbru, PharmD, CEO and founder of AINGENS, about why life sciences teams still spend months procuring clunky systems, why highly trained experts are buried in literature searches and manual drafting, and why generative AI may finally be mature enough to change that. As Dr. Ogbru puts it, "Telling that scientific story… it's difficult, it's painful. It requires expertise, specialized training. It takes time."

      Continue Reading
      DI: Episode 228
      DI: Episode 228

      Life Sciences Turned Expertise into Admin
      For Dr. Ogbru, the core failure is not a lack data or expertise. It is The systems surrounding them. These systems are still too slow, fragmented, and labor-intensive. In the episode, he describes an industry where teams are already stretched thin, then forced to spend months or even years identifying, buying, or building software. "It could take you a year to a couple of years to actually get your solution," he says. "A lot of times when we finally got that solution, it did not meet the expectation."

      The burden falls most heavily on the people least meant to carry it. Instead of focusing on scientific judgment, strategy, and communication, highly trained professionals end up spending their time documenting, searching, formatting, and managing systems that add work instead of removing it. Dr. Ogbru points literature search as one of the clearest examples: PubMed contains more than 35 million citations, and even experienced professionals can spend hours or days trying to locate the few papers that actually answer a question. "You could miss things," he says. "We are human and we're not perfect."

      That challenge becomes even harder in a space where speed cannot come at the expense of compliance. Life sciences teams are not just working under scientific standards, but under layered regulatory, company-specific, and promotional guardrails that affect what can be said, how it can be said, and when. The result is a system where content moves slowly, personalization is difficult, and critical information often reaches patients, clinicians, and researchers later than it should.

      The Future of Science Will Always Need the Scientist
      Generative AI is not the answer by itself. The answer is pairing the technology with deep domain expertise and workflows built for real scientific work. Dr. Ogbru describes his own turning point after testing ChatGPT and getting poor results. "The problem was me. I didn't know how to use it", he says. That realization became the foundation for AINGENS: AI only becomes useful when it is shaped around the pain points experts face and deployed as a tool, not as a replacement for judgment.

      That philosophy is built directly into the company's first platform, MACG (Medical Affairs Content Generator). Dr. Ogbru says it was designed so that "the professional is in control. You are the driver, you are the expert." The platform handles the mundane, time-consuming tasks such as literature search, drafting, and formatting, while the human expert applies regulatory knowledge, scientific context, and the guardrails that keep content accurate and compliant. In his words, used appropriately, AI "can actually do amazing things."

      For Dr. Ogbru, the bigger vision reaches beyond productivity. He wants life sciences to move faster not just so teams work better, but so accurate information can outrun bad information. "Misinformation is a big problem in life sciences," he says, recalling patients who refused proven treatments because of something false they had heard elsewhere. That is why his long-term goal is not simply automation, but better translation of scientific data into usable knowledge.

      Links

      Disrupting Pharma's Paperwork Pandemic: The AI Built for Real Science with Ome Ogbru

      Disruption Interruption is the podcast where you will hear from today's biggest Industry Disruptors. Learn what motivated them to bring about innovation and how they overcame opposition to adoption.

      https://omny.fm/shows/disruption-interruption/disrupting-pharma-s-paperwork-pandemic-the-ai-built-for-real-science-with-ome-ogbru

      LinkedIn: https://www.linkedin.com/in/ome-ogbru-pharmd/
      Company Website: https://aingens.com

      About Disruption Interruption™
      Disruption is happening on an unprecedented scale, impacting all manner of industries — MedTech, Finance, IT, eCommerce, shipping, logistics, and more — and COVID has moved their timelines up a full decade or more. But WHO are these disruptors and when did they say, "THAT'S IT! I'VE HAD IT!"? Time to Disrupt and Interrupt with host Karla Jo "KJ" Helms, veteran communications disruptor. KJ interviews badasses who are disrupting their industries and altering economic networks that have become antiquated with an establishment resistant to progress. She delves into uncovering secrets from industry rebels and quiet revolutionaries that uncover common traits — and not-so-common — that are changing our economic markets… and lives. Visit the world's key pioneers that persist to success, despite arrows in their backs at www.disruption-interruption.com.

      About Ome Ogbru
      Ome Ogbru, PharmD, is the CEO and Founder of AINGENS, a life sciences software company building evidence-first AI platforms for scientific and medical workflows. With over 20 years of experience across pharma, biotech, and healthcare, his background includes roles as a clinical pharmacist, professor, and global medical information leader, where he worked at the intersection of science, regulation, and content creation.

      Driven by firsthand experience with the inefficiencies of evidence-based content workflows, Dr. Ogbru founded AINGENS to develop practical, enterprise-ready solutions that improve how scientific information is created, reviewed, and delivered. Through its flagship platform, MACg (Medical Affairs Content Generator), he focuses on enabling faster, more reliable medical and scientific communication without compromising accuracy or compliance. For more about AINGENS, visit https://aingens.com/macg.

      About Karla Jo Helms
      Karla Jo Helms is the Chief Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™. Karla Jo learned firsthand how unforgiving business can be when millions of dollars are on the line — and how the control of public opinion often determines whether one company is happily chosen, or another is brutally rejected. Being an alumnus of crisis management, Karla Jo has worked with litigation attorneys, private investigators, and the media to help restore companies of goodwill into the good graces of public opinion — Karla Jo operates on the ethic of getting it right the first time, not relying on second chances and doing what it takes to excel. Helms speaks globally on public relations, how the PR industry itself has lost its way, and how, in the right hands, corporations can harness the power of Anti-PR to drive markets and impact market perception.

      References

      • Levy, D. R., Withall, J. B., Mishuris, R. G., Tiase, V., Diamond, C., Douthit, B., Grabowska, M., Lee, R. Y., Moy, A. J., Sengstack, P., Adler-Milstein, J., Detmer, D. E., Johnson, K. B., Cimino, J. J., Cato, K., & Rossetti, S. C. (2024). Defining documentation burden (DocBurden) and excessive DocBurden for all health professionals: A scoping review. Applied Clinical Informatics, 15(5), 898–913. doi.org/10.1055/a-2385-1654 
      • National Library of Medicine. (n.d.). PubMed. pubmed.ncbi.nlm.nih.gov/
      • Obika, D., Kelly, C., Ding, N., Farrance, C., Krause, J., Mittal, P., Cheung, D., Cole-Lewis, H., Elish, M., Karthikesalingam, A., Webster, D., Patel, B., & Howell, M. (2024). Safety principles for medical summarization using generative AI. Nature Medicine, 30(12), 3417–3419. doi.org/10.1038/s41591-024-03313-y

      Media Inquiries:
      Karla Jo Helms
      JOTO PR™ 
      727-777-4629

      SOURCE Disruption Interruption

      Modal title

      Also from this source

      Disrupting AI Spending: Brian Kolbusz Targets the Pilot-to-Scale Gap

      Disrupting AI Spending: Brian Kolbusz Targets the Pilot-to-Scale Gap

      Forty-four percent of CEOs struggle to demonstrate financial returns from artificial intelligence (AI) to stakeholders, according to Gartner. The...

      Disrupting Intellectual Property: Mary Guzman Insures the "How" Behind Innovation

      Disrupting Intellectual Property: Mary Guzman Insures the "How" Behind Innovation

      Corporate intangible assets topped $97 trillion globally in 2025, growing 23% from the previous year, according to the World Intellectual Property...

      More Releases From This Source

      Explore

      Radio

      Radio

      Entertainment

      Entertainment

      Health Care & Hospitals

      Health Care & Hospitals

      Computer & Electronics

      Computer & Electronics

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.